The nucleocapsid protein’s main job is to package and protect the virus’s genetic material. Like several other coronavirus proteins, it’s also known to suppress the body’s early antiviral defenses, helping the virus get a foothold.
Scientists led by virologist Melody Li set out to see whether SARS-CoV-2’s version of this immune-dampening protein worked the same way as those found in SARS and MERS, earlier coronaviruses known to cause severe disease.